Furthermore, the current drugs used for AD treatment include acetylcholinesterase inhibitors (AChEIs), N-methyl-D-aspartate receptor (NDMAR) antagonist, and anti-amyloid beta monoclonal antibodies. This evidence concerns the gene ACHE and Alzheimer disease.